Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from In vitro and In vivo Oncology

  • You have access
    FAP-targeted molecular radiotherapy synergizes with checkpoint inhibitor immunotherapy to attenuate tumor growth in a murine model of non-small cell lung cancer
    Kathleen Capaccione, Mikhail Doubrovin, Brian Braumuller, Dev Leibowitz, Nikunj Bhatt, Andrei Molotkov, Fatemeh Momen-Heravi and Akiva Mintz
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2564;
  • You have access
    Longitudinal multi-tracer PET/CT characterization of oncogene-driven hepatocellular carcinoma formation in two transgenic mouse models
    Mari Teuter, Asha Balakrishnan, Daniel Ahrens, Tobias Ross, Michael Ott, Frank Bengel and Jens Bankstahl
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2577;
  • You have access
    Initial evaluation of Cerium-134 (134Ce) for immunoPET
    Mark Longtine, Kyuhwan Shim, Diane Abou, Lucy Summer, Thomas Voller, Daniel Thorek and Richard Wahl
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2578;
  • You have access
    Therapeutic efficacy of an 211At-labeled anti-HER2 single domain antibody fragment (sdAb) in mice: comparison with its 131I-labeled analogue
    Yutian Feng, Rebecca Meshaw, Ganesan Vaidyanathan and Michael Zalutsky
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2565;
  • You have access
    The combination of 225Ac-anti-CD33 radioimmunoconjugate and CD47 blockade enhances survival in a preclinical model of acute myeloid leukemia
    Caroline Jennings, Jason Li, Megan McCloskey, Sagarika Pachhal, Emily Greer, Amanda Chin, Eileen Geoghegan, Qing Liang, Jesse Hwang, Monideepa Roy, Mary Chen, Helen Kotanides, Dale Ludwig and Denis Beckford
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2570;
  • You have access
    Monitoring Therapeutic Response to FAP CAR T Cells using [18F]AlF-FAPI-74 PET
    Iris Lee, Estela Noguera-Ortega, Zebin Xiao, Leslie Todd, Maria Liousia, Kexiang Xu, Kimberly Edwards, Steven Albelda, Ellen Puré and Mark Sellmyer
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2499;
  • You have access
    Conjugation and radiolabelling of [225Ac]Ac-macropa-tzPEG3Sq-ch806, a tumour-specific anti-EGFR antibody, and preclinical evaluation in a murine glioma model
    Christian Wichmann, Katherine Morgan, Nancy Guo, Hui Gan, Ingrid Burvenich, Paul Donnelly and Andrew Scott
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2569;

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
SNMMI

© 2025 SNMMI

Powered by HighWire